IPEC: Updated Qualification-Guide published
Recommendation

27-29 October 2026
Practical Approaches for Assessing the Risks of Impurities
IPEC Europe (International Pharmaceutical Excipients Council Europe) has published the updated Version 3 of the “Qualification of Excipients for Use in Pharmaceuticals: Guide & Checklist” on its website. First published in 2008, this guide provides recommendations for good practices in a risk-based process for qualifying excipients from new or existing suppliers. It supports the establishment of effective relationships between suppliers and users, facilitates the smooth use of excipients, and helps ensure compliance with regulatory and GMP requirements. The guide includes a checklist for identifying the essential information required to qualify excipients used in medicinal products.
Additional Section on Nitrosamines
The key substantive change in Version 3 (2026) compared with Version 2 (2020) is the inclusion of a dedicated section on nitrosamines (2.4.6.5). This section clarifies that nitrosamine risk assessments for finished medicinal products should take excipients into account, even where there is no explicit regulatory obligation for excipient manufacturers to test for nitrites or nitrosamines or to communicate relevant data. Version 3 also refers to an IPEC Nitrosamines Template to support the exchange of information.
The complete document is available on the IPEC website and can be downloaded after registration.
Related GMP News
14.09.2026PFAS restriction: Commission highlights Importance of critical Medical Applications
09.09.2026IPEC: New Stability Guide for Excipients Published
12.08.2026FDA Warning Letter for an Indian API Manufacturer
29.07.2026EPRS publishes a Briefing Paper on PFAS
15.07.2026GMP for Active Substances - What are the fundamental Requirements of the ICH Q7 Guideline? - Part 2


